Pegaron

Avaiability: in stock

Generic: Pegylated Interferon Alpha 2-a

Strength: 180 mcg

Form: Injection

 

Product Description

Pegaron 180 micrograms solution for injection

INDICATIONS

Chronic hepatitis B

Pegaron is indicated for the treatment of hepatitis B envelope antigen (HBeAg)-positive or HBeAg-negative chronic hepatitis B (CHB) in adult patients with compensated liver disease and evidence of viral replication, increased ALT and histologically verified liver inflammation and/or fibrosis.

Chronic hepatitis C

Adult patients

Pegaron is indicated in combination with other medicinal products, for the treatment of chronic hepatitis C (CHC) in patients with compensated liver disease.

For hepatitis C virus (HCV) genotype specific activity.

Paediatric patients 5 years of age and older:

Pegaron in combination with ribavirin is indicated for the treatment of chronic hepatitis C in treatment-naïve children and adolescents 5 years of age and older who are positive for serum HCV-RNA.

When deciding to initiate treatment in childhood, it is important to consider growth inhibition induced by combination therapy. The reversibility of growth inhibition is uncertain.

Certifications